Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s Sensex 
Returns Beta
Beta has not been calculated since enough price history is not available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.10%
EBIT Growth (5y)
25.00%
EBIT to Interest (avg)
0.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
23.08%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.06%
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
0
Price to Book Value
5.27
EV to EBIT
18.78
EV to EBITDA
15.92
EV to Capital Employed
4.31
EV to Sales
2.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.89%
ROE (Latest)
14.82%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
Bearish
OBV
Shareholding Snapshot : Jul 2024
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Herrik Mountbaton Shah (31.12%)
Highest Public shareholder
Pure Broking Private Ltd-Prop (1.42%)
Individual Investors Holdings
About Hamps Bio Limited 
Hamps Bio Limited
Micro Cap
Pharmaceuticals & Drugs
Hamps Bio Limited was originally incorporated under the name "Hamps Bio Private Limited" vide Certificate of Incorporation issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli on January 02, 2007. Subsequently, the Company status changed to Public Limited and the name of Company was changed to "Hamps Bio Limited". The fresh Certificate of Incorporation consequent to conversion was issued on July 12, 2023 by the Registrar of Companies, Ahmedabad, Gujarat.
Company Coordinates 
No Company Details Available